News from Johnson & Johnson
Stay current with all the latest and breaking news about Johnson & Johnson, compare headlines and perspectives between news sources on stories happening today. In total, 143 stories have been published about Johnson & Johnson which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Johnson & Johnson News
Latest News Stories
Johnson & JohnsonOn Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion. Operational growth was 3.9%, and adjusted operational growth was 4.0%. After good earnings results, Cantor Fitzgerald remains positive on Johnson & Johnson’s stock. The analyst…See the Story
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future - Johnson & Johnson (NYSE:JNJ)
100% Center coverage: 1 sources
Johnson & Johnson · TorontoTORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- TRC Capital Investment Corporation (TRC) announced today that based on current market conditions, TRC has amended the terms of its tender offer for up to 1,000,000 common shares of Johnson & Johnson (the Company) and has decreased the offer price payable to US$142.88 per share from US$151.23 per share. TRC also announced that its offer will still expire at 12:01 a.m. New York City time on May 2, 2024…See the Story
TRC Amends Its Tender Offer for Johnson & Johnson
100% Center coverage: 1 sources
Johnson & Johnson · New BrunswickJohnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion, according to data from Benzinga Pro. Johnson & Johnson also raised its quarterly dividend by 4.2% from $1.19 per share to $1.24…See the Story
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results - Johnson & Johnson (NYSE:JNJ)
100% Center coverage: 1 sources
Johnson & Johnson · United StatesThis morning, Johnson & Johnson announced it raked in $21.4 billion this quarter – a 2.3 percent increase over last year. They make billions while charging Americans prices up to four times higher than in other countries, forcing patients to...See the Story
Protect Our Care Wisconsin: GREED WATCH: Johnson & Johnson raked in over $21 billion in revenue in the first three months of 2024
100% Center coverage: 1 sources
Johnson & JohnsonOn Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended…See the Story
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff - Johnson & Johnson (NYSE:JNJ)
100% Center coverage: 1 sources
Wall Street · New BrunswickJohnson & Johnson’s first-quarter drug sales narrowly outpaced Wall Street expectations as the company beat profit estimates, a step towards boosting profitability after the spinoff of its consumer division.See the Story
J&J Pharma Sales Edge Out Street Estimates as Profit Beats
100% Left coverage: 1 sources
